These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25859669)

  • 21. Social science. A risky science communication environment for vaccines.
    Kahan DM
    Science; 2013 Oct; 342(6154):53-4. PubMed ID: 24092722
    [No Abstract]   [Full Text] [Related]  

  • 22. A crisis of public confidence in vaccines.
    Black S; Rappuoli R
    Sci Transl Med; 2010 Dec; 2(61):61mr1. PubMed ID: 21148125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust?
    Scherer LD; Shaffer VA; Patel N; Zikmund-Fisher BJ
    Vaccine; 2016 May; 34(21):2424-2429. PubMed ID: 27049120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mistrust surrounding vaccination recommendations by the Japanese government: results from a national survey of working-age individuals.
    Wada K; Smith DR
    BMC Public Health; 2015 Apr; 15():426. PubMed ID: 25928236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facts to help you keep pace with the vaccine conversation.
    Campos-Outcalt D
    J Fam Pract; 2019; 68(6):341;342;344;346. PubMed ID: 31381622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weighing the risks and benefits of vaccination.
    Glickman LT
    Adv Vet Med; 1999; 41():701-13. PubMed ID: 9890055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoring confidence in vaccines by explaining vaccine safety monitoring: is a targeted approach needed?
    Casiday RE; Cox AR
    Drug Saf; 2006; 29(12):1105-9. PubMed ID: 17147457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccine opponents and sceptics. History, background, arguments, interaction].
    Meyer C; Reiter S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Dec; 47(12):1182-8. PubMed ID: 15583889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?
    MacDonald NE; Smith J; Appleton M
    Biologicals; 2012 Sep; 40(5):384-8. PubMed ID: 21993306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encouraging spontaneous reporting of adverse effects.
    Prescrire Int; 2015 Feb; 24(157):53. PubMed ID: 25802925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical Misinformation.
    Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen PS; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C;
    Circ Heart Fail; 2019 Feb; 12(2):e005869. PubMed ID: 30688079
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical Misinformation.
    Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen PS; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
    Circ Cardiovasc Imaging; 2019 Feb; 12(2):e008809. PubMed ID: 30688516
    [No Abstract]   [Full Text] [Related]  

  • 34. Cryptic vaccine-associated adverse events: The critical need for a new vaccine safety surveillance paradigm to improve public trust in vaccines.
    Poland GA; Black S
    Vaccine; 2024 Mar; 42(8):1860-1862. PubMed ID: 38296703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine Rejecting Parents' Engagement With Expert Systems That Inform Vaccination Programs.
    Attwell K; Leask J; Meyer SB; Rokkas P; Ward P
    J Bioeth Inq; 2017 Mar; 14(1):65-76. PubMed ID: 27909947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflections of a Vaccinologist: Lessons Learned About What We Can Do to Improve Trust in Vaccines and Vaccine Programsa.
    Halsey NA
    J Pediatric Infect Dis Soc; 2017 Mar; 6(1):3-8. PubMed ID: 26611984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is It Time for Vaccination to "Go Viral"?
    Philip RK; Shapiro M; Paterson P; Glismann S; Van Damme P
    Pediatr Infect Dis J; 2016 Dec; 35(12):1343-1349. PubMed ID: 27626913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of the patient voice in vaccination and vaccine safety-are we listening?
    Holt D; Bouder F; Elemuwa C; Gaedicke G; Khamesipour A; Kisler B; Kochhar S; Kutalek R; Maurer W; Obermeier P; Seeber L; Trusko B; Gould S; Rath B
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S146-S153. PubMed ID: 27939015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.
    Cohet C; Rosillon D; Willame C; Haguinet F; Marenne MN; Fontaine S; Buyse H; Bauchau V; Baril L
    Vaccine; 2017 May; 35(23):3041-3049. PubMed ID: 28465097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunities and challenges of Web 2.0 for vaccination decisions.
    Betsch C; Brewer NT; Brocard P; Davies P; Gaissmaier W; Haase N; Leask J; Renkewitz F; Renner B; Reyna VF; Rossmann C; Sachse K; Schachinger A; Siegrist M; Stryk M
    Vaccine; 2012 May; 30(25):3727-33. PubMed ID: 22365840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.